Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAligos Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$4.55 | -$2.00 | -$2.98 |
| Q2 2025 | 2 | -$2.49 | -$2.24 | -$2.36 |
| Q3 2025 | 2 | -$2.05 | -$1.75 | -$1.90 |
| Q4 2025 | 2 | -$2.61 | -$2.05 | -$2.33 |
| Q1 2026 | 2 | -$2.36 | -$1.84 | -$2.10 |
| Q2 2026 | 1 | -$2.12 | -$2.12 | -$2.12 |
| Q3 2026 | 1 | -$1.82 | -$1.82 | -$1.82 |
| Q4 2026 | 1 | -$1.82 | -$1.82 | -$1.82 |
| Q1 2027 | 1 | -$6.81 | -$6.81 | -$6.81 |
| Q2 2027 | 1 | -$6.38 | -$6.38 | -$6.38 |
Aligos Therapeutics, Inc. Earnings Date And Information
Aligos Therapeutics, Inc. last posted its earnings results on Thursday, November 6th, 2025. The company reported $-3.04 earnings per share for the quarter, missing analysts' consensus estimates of $-2.09 by $0.95. The company had revenue of 741.00 K for the quarter and had revenue of 3.95 M for the year. Aligos Therapeutics, Inc. has generated $-21 earnings per share over the last year ($-20.94 diluted earnings per share) and currently has a price-to-earnings ratio of -1.21. Aligos Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 5th, 2026 based on prior year's report dates.
Aligos Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | -$2.09 | -$3.04 | -0.95 | $500.00 K | $741.00 K |
| 08/06/2025 | Q2 2025 | -$2.35 | -$1.53 | 0.82 | $433.33 K | $965.00 K |
| 05/06/2025 | Q1 2025 | -$2.80 | $5.12 | 7.92 | N/A | $311.00 K |
| 03/10/2025 | Q4 2024 | -$2.63 | -$13.08 | -10.45 | N/A | $629.00 K |
| 11/06/2024 | Q3 2024 | -$2.15 | -$3.07 | -0.92 | $333.33 K | $1.27 M |
| 08/06/2024 | Q2 2024 | -$4.00 | $0.81 | 4.81 | $1.06 M | $1.06 M |
| 05/07/2024 | Q1 2024 | -$4.75 | -$2.24 | 2.51 | N/A | $986.00 K |
| 03/12/2024 | Q4 2023 | -$6.75 | -$1.12 | 5.63 | N/A | $2.68 M |
| 11/02/2023 | Q3 2023 | -$12.00 | -$0.41 | 11.59 | $2.50 M | $3.24 M |
| 08/03/2023 | Q2 2023 | -$12.50 | -$0.43 | 12.07 | N/A | $6.89 M |
| 05/04/2023 | Q1 2023 | -$12.25 | -$0.53 | 11.72 | N/A | $2.72 M |
| 03/09/2023 | Q4 2022 | -$12.25 | -$0.51 | 11.74 | $2.15 M | $3.54 M |
| 11/02/2022 | Q3 2022 | -$14.25 | -$0.44 | 13.81 | $750.00 K | $4.11 M |
| 08/04/2022 | Q2 2022 | -$16.25 | -$0.47 | 15.78 | N/A | $3.69 M |
| 05/04/2022 | Q1 2022 | -$16.50 | -$0.84 | 15.66 | $2.18 M | $2.57 M |
| 03/10/2022 | Q4 2021 | -$20.75 | -$0.89 | 19.86 | N/A | $367.00 K |
| 11/04/2021 | Q3 2021 | -$20.75 | -$0.78 | 19.97 | N/A | $1.54 M |
| 08/05/2021 | Q2 2021 | -$20.25 | -$0.79 | 19.46 | N/A | $1.55 M |
| 05/10/2021 | Q1 2021 | -$22.50 | -$0.74 | 21.76 | $1.07 M | $910.00 K |
| 03/23/2021 | Q4 2020 | -$0.82 | -$1.09 | -0.27 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aligos Therapeutics, Inc. Earnings: FAQ's
Aligos Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 5th, 2026 based offlast year's report dates.
The conference call for Aligos Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Aligos Therapeutics, Inc.'s latest earnings report can be read online.
Aligos Therapeutics, Inc. (:ALGS) has a recorded annual revenue of $3.95 M.
Aligos Therapeutics, Inc. (:ALGS) has a recorded net income of $-131,211,000.Aligos Therapeutics, Inc. has generated $-20.94 earnings per share over the last four quarters.
Aligos Therapeutics, Inc. (:ALGS) has a price-to-earnings ratio of -1.21 and price/earnings-to-growth ratio is -5.07.